Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells
- 1 April 1996
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 121 (2) , 167-173
- https://doi.org/10.1016/0021-9150(95)05709-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Non-peptide Angiotensin Agonist: FUNCTIONAL AND MOLECULAR INTERACTION WITH THE AT1 RECEPTORPublished by Elsevier ,1995
- Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor modelTrends in Pharmacological Sciences, 1994
- Angiotensin receptor subtypes in rat, rabbit and monkey tissues: Relative distribution and species dependencyLife Sciences, 1991
- Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteriesLife Sciences, 1991
- Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.Hypertension, 1991
- Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.Hypertension, 1991
- Biochemical Characterization of Two Angiotensin II Receptor Subtypes in the RatJournal of Cardiovascular Pharmacology, 1990
- Angiotensin II and noradrenaline increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscleBiochemical and Biophysical Research Communications, 1990
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.The Journal of cell biology, 1986
- Significance of the vascular renin-angiotensin pathway.Hypertension, 1986